A novel immunohistochemical assay for the detection of Ebola virus in skin: Implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever

Journal of Infectious Diseases

Volumn 179, Issue SUPPL. 1, 1999, Pages

  Zaki, Sherif R ^a,b,c,d,e   Shieh, Wun Ju ^a,b,c,d   Greer, Patricia W ^a,b,c,d   Goldsmith, Cynthia S ^a,b,c,d   Ferebee, Tara ^a,b,c,d   Katshitshi, Jacques ^a,b,c,d   Tshioko, F Kweteminga ^a,b,c,d   Bwaka, Mpia A ^a,b,c,d   Swanepoel, Robert ^a,b,c,d   Calain, Philippe ^a,b,c,d   Khan, Ali S ^a,b,c,d   Lloyd, Ethleen ^a,b,c,d   Rollin, Pierre E ^a,b,c,d   Ksiazek, Thomas G ^a,b,c,d   Peters, Clarence J ^a,b,c,d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Red Cross/Hop Gen de Ref de K ^*  (Democratic Republic Congo)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN;

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ANTIGEN DETECTION; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ELECTRON MICROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MONITORING; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; SKIN; VIRUS HEMORRHAGIC FEVER; VIRUS ISOLATION;

EID: 0033038993     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514319     Document Type: Conference Paper

References (50)

1. 1. Centers for Disease Control and Prevention. Outbreak of Ebola viral hemorrhagic fever - Zaire, 1995. MMWR Morb Mortal Wkly Rep 1995; 44:381-2.
2. 2. Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of Congo: clinical observations in 103 patients. J Infect Dis 1999; 179(suppl 1):S1-7.
3. 3. Khan AS, Tshioko FK, Heymann DH, et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(suppl 1):S76-86.
4. 4. Sanchez A, Ksiazek TG, Rollin PE, et al. Reemergence of Ebola virus in Africa. Emerg Infect Dis 1995; 1:96-7.
5. 5. Muyembe T, Kipasa M. Ebola haemorrhagic fever in Kikwit, Zaire [letter]. Lancet 1995; 345:1448.
6. 6. Sanchez A, Ksiazek TG, Rollin PE, et al. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis 1999; 179(suppl 1):S164-9.
7. 7. Ksiazek TG, Rollin PE, Williams AJ, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(suppl 1):S177-87.
8. 8. Murphy FA, Peters CJ. Ebola virus: where does it come from and where is it going? In: Krause RM, ed. Emerging infections. New York: Academic Press, 1998;375-410.
9. 9. Kerstiëns B, Matthys F. Interventions to control virus transmission during an outbreak of Ebola hemorrhagic fever: experience from Kikwit, Democratic Republic of the Congo. J Infect Dis 1999; 179(suppl 1): S263-7.
10. 10. Peters CJ, Sanchez A, Rollin PE, Ksiazek TG, Murphy FA. Filoviridae: Marburg and Ebola viruses. In: Fields virology. Fields BN, Knipe DM, Howley PM, et al., eds. New York: Lippincott-Raven, 1996; 1161-76.
11. 11. Sanchez A, Trappier SG, Mahy BW, Peters CJ, Nichol ST. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci USA 1996; 93:3602-7.
12. 12. Peters CJ, Zaki SR, Rollin PE. Viral hemorrhagic fevers. In: Mandell GL, ed. Atlas of infectious diseases. Philadelphia: Churchill Livingstone, 1997; 10.2-.26.
13. 13. Zaki SR, Peters CJ. Viral hemorrhagic fevers. In: Connor DH, Chandler FW, Schwartz DA, Manz HJ, Lack EE, eds. Diagnostic pathology of infectious diseases. Stamford, CT: Appleton and Lange, 1997; 347-64.
14. 14. Johnson KM, Lange JV, Webb PA, Murphy FA. Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet 1977; 1:569-71.
15. 15. Ksiazek TG, Rollin PE, Jahrling PB, Johnson E, Dalgard DW, Peters CJ. Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol 1992; 30:947-50.
16. 16. Peters CJ, Leduc JW. An introduction to Ebola: the virus and its disease. J Infect Dis 1999; 179(suppl 1):ix-xvi.
17. 17. Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis 1999; 179(suppl 1):S192-8.
18. 18. Kalongi Y, Mwanza K, Tshisuaka M, et al. Isolated case of Ebola hemorrhagic fever with mucormycosis complications, Kinshasa, Democratic Republic of the Congo. J Infect Dis 1999; 179(suppl 1):S15-7.
19. 19. Ksiazek TG. Laboratory diagnosis of filovirus infections in nonhuman primates. Lab Anim 1991;20:34-46.
20. 21. Zaki SR, Greer PW, Coffield LM, et al. Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. Am J Pathol 1995; 146: 552-79.
21. 21. Villinger F, Rollin PE, Brar SS, et al. Markedly elevated levels of interferon (IFN)-γ, IFN-α, interleukin (IL)-2, IL-10, and tumor necrosis factor-α associated with fatal Ebola virus infection. J Infect Dis 1999; 179(suppl 1):S188-91.
22. 22. Baskerville A, Bowen ETW, Platt GS, McArdell LB, Simpson DIH. The pathology of experimental Ebola virus infection in monkeys. J Pathol 1978; 125:131-8.
23. 23. Murphy FA, Simpson DIH, Whitfield SG, Zlotnik I, Carter GB. Marburg virus infection in monkeys. Ultrastructural studies. Lab Invest 1971;24: 279-91.
24. 24. Pereboeva LA, Tkachev VK, Kolesnikova LV, Krendeleva LI, Ryabchikova EI, Smolina MP. Ultrastructural changes of guinea pig organs in sequential passages of Ebola virus. Vopr Virusol 1993; 38:179-82.
25. 25. Jaax NK, Davis KJ, Geisbert TJ, et al. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med 1996; 120:140-55.
26. 26. Peters CJ. Pathogenesis of viral hemorrhagic fevers. In: Nathanson N, Ahmed R, Gonzalez-Scarano F, et al, eds. Viral pathogenesis. Philadelphia: Lippincott-Raven, 1996.
27. 27. Swanepoel R, Leman PA, Burt FJ, et al. Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis 1996;2:321-5.
28. 28. Davis KJ, Anderson AO, Geisbert TW, et al. Pathology of experimental Ebola virus infection in African green monkeys: involvement of fibroblastic reticular cells. Arch Pathol Lab Med 1997; 121:805-19.
29. 29. Xu L, Sanchez A, Yang ZY, et al. Immunization for Ebola virus infection. Nat Med 1998;4:37-42.
30. 30. Bray M, Davis K, Gisbert T, Schmaljohn C, Huggins J. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis 1998; 178:651-61.
31. 31. Jahrling PB, Geisbert TW, Jaax NK, Hanes MA, Ksiazek TG, Peters CJ. Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic. Arch Virol 1996; 115-34.
32. 32. Zaki SR, Goldsmith CS. Pathologic features of filovirus infections. Curr Top Microbiol Immunol 1998; 235:97-116.
33. 33. Bonnet MJ, Akamituna P, Mazaya A. Unrecognized Ebola hemorrhagic fever at Mosango Hospital during the 1995 epidemic in Kikwit, Democratic Republic of the Congo. Emerg Infect Dis 1998;4:508-10.
34. 34. Saliou P, Fred L, Richard ER, Crawford PJ. La surveillance épidémiologique des maladies transmissibles dans les pays tropicaux: les principles et une application pratique pour trois maladies soumises au Reglement Sanitaire International (Choléra, Fièvre Jaune et Variole). Méd d'Afrique Noire 1977;24:93-113.
35. 35. Soper F, Richard ER, Crawford PJ. The routine post-mortem removal of liver tissue from rapidly fatal fever cases for the discovery of silent yellow fever foci. Am J Hyg 1934; 19:549-66.
36. 36. Schnittler HJ, Mahner F, Drenckhahn D, Klenk HD, Feldmann H. Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease. J Clin Invest 1993; 91:1301-9.
37. 37. Ellis DS, Bowen ETW, Simpson DIH, Stamford S. Ebola virus: a comparison, at ultrastructural level, of the behaviour of the Sudan and Zaire strains in monkeys. Br J Exp Pathol 1978;59:584-93.
38. 38. Dietrich M, Schumacher HH, Peters D, Knobloch J. Human pathology of Ebola (Maridi) virus infection in the Sudan. In: Pattyn SR, ed. Ebola virus haemorrhagic fever. Amsterdam: Elsevier/North-Holland Biomedical Press, 1978;37-41.
39. 39. Ellis DS, Simpson DIH, Francis DP, et al. Ultrastructure of Ebola virus particles in human liver. J Clin Pathol 1978;31:201-8.
40. 40. Rippey JJ, Schepers NJ, Gear JHS. The pathology of Marburg virus disease. S Afr Med J 1984;66:50-4.
41. 41. Murphy FA, van der Groen G, Whitfield SG, Lange JV. Ebola and Marburg virus morphology and taxonomy. In: Pattyn SR, ed. Ebola virus haemorrhagic fever. Amsterdam: Elsevier/North-Holland Biomedical Press, 1978;61-82.
42. 42. Centers for Disease Control and Prevention and World Health Organization. Infection control for viral hemorrhagic fevers in the African health care setting. Atlanta: CDC, 1998:1-198.
43. 43. Shieh WJ, Demby A, Merdel S, et al. High risk autopsy of fatal Lassa fever cases in Sierra Leone [abstract]. Lab Invest 1998; 78:147A.
44. 44. Heymann DL, Weisfeld JS, Webb PA, Johnson KM, Cairns T, Berquist H. Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. J Infect Dis 1980; 142:372-6.
45. 45. Busico KM, Marshall KL, Ksiazek TG, et al. Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(suppl 1):S102-7.
46. 46. Georges-Courbot MC, Sanchez A, Lu CY, et al. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emcerg Infect Dis 1997;3:59-62.
47. 47. Le Guenno B, Formenty P, Wyers M, Gounon P, Walker F, Boesch C. Isolation and partial characterization of a new strain of Ebola virus. Lancet 1995;345:1271-4.
48. 48. Lloyd ES, Zaki SR, Rollin PE, et al. Long-term disease surveillance in Bandundu region, Democratic Republic of the Congo: a model for early detection and prevention of Ebola hemorrhagic fever. J Infect Dis 1999; 179(suppl 1):S275-81.
49. 49. Dowell SF, Mukunu R, Ksiazek TG, et al. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(suppl 1):S87-91.
50. 50. Tomori O, Bertolli J, Rollin PE, et al. Serologic survey among hospital and health center workers during the Ebola hemorrhagic fever outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(suppl 1):S98-101.